- Nexalin Technology (NXL, Financial) is set to host an investor webinar on June 3, 2025, at 4:15 p.m. ET.
- The webinar will cover the company's DIFS™ technology and updates on the Gen-3 HALO™ Clarity headset and Virtual Clinic model for at-home treatment.
- Nexalin aims to expand in the $537 billion mental health market, highlighting clinical collaborations and international regulatory approvals.
Nexalin Technology (NXL) announced that it will host a live investor webinar on June 3, 2025, at 4:15 p.m. ET. The event will feature CEO Mark White presenting the company's proprietary Deep Intracranial Frequency Stimulation (DIFS™) technology, designed to revolutionize mental healthcare. Attendees will receive updates on Nexalin's Gen-3 HALO™ Clarity headset and the Virtual Clinic model, both of which facilitate scalable at-home mental health treatment.
The presentation will shed light on Nexalin's clinical collaborations with renowned institutions like UC San Diego, alongside showcasing the company's strides in securing international regulatory approvals. With an ambitious strategy aimed at expanding its footprint in the $537 billion mental health market, Nexalin is poised for significant growth. The event will also explore the company's patented technology capable of real-time AI-driven patient monitoring, emphasizing the global expansion strategy to tap the high-growth neurostimulation sector.
To participate in this informative session, interested investors can register for free by visiting the provided signup link. Additionally, a live Q&A session will be hosted by CEO Mark White, allowing participants to engage directly with company leadership. Questions can be submitted in advance or during the webinar.
